January 13, 2012

HELIX BIOPHARMA CORP. ANNOUNCES Q1 2012 RESULTS (PDF)

(Aurora, Ontario) – Helix BioPharma Corp. (TSX, NYSE Amex, FSE: “HBP”), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, today announced financial results for the quarter ended October 31, 2011.